Your browser is no longer supported. Please, upgrade your browser.
KL Acquisition Corp
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.00%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float28.75M Perf Month-0.70%
Income- PEG- EPS next Q- Inst Own33.95% Short Float0.00% Perf Quarter-0.60%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.00 Perf Half Y-5.88%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.80 - 10.74 Perf YTD-3.41%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-7.64% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low1.22% ATR0.04
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.10 Volatility0.29% 0.32%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close9.92
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume38.14K Price9.92
Recom- SMA200.20% SMA50-0.26% SMA200-1.55% Volume0 Change0.00%
Apr-11-21 05:42AM  
Feb-24-21 04:05PM  
Jan-12-21 12:30PM  
Jan-07-21 06:14PM  
KL Acquisition Corp is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus investment effort on life sciences, which includes medical devices, diagnostics, and life sciences tools and instrumentation. The company was incorporated in 2020 and is based in New York, New York.